|
Article Excerpt
M2 PRESSWIRE-31 May 2006-Stockguru.com: StockGuru Movers for Wednesday May 31, 2006 - American Ammunition Adds New Products in the Cowboy Action Market while ERF Wireless to Re-sell SaTMAX(TM)(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:31052006
Dallas, Texas - StockGuru Movers for Wednesday include: Protein Polymer Technologies, Inc. (OTCBB:PPTI), ReGen Biologics, Inc. (OTCBB: RGBI), American Ammunition, Inc. (OTCBB:AAMU), ERF Wireless (OTCBB:ERFW), Force Protection, Inc. (OTCBB:FRPT), and Zunicom, Inc. (OTCBB:ZNCM). StockGuru Movers feature companies with significant moves in either volume or price in the past two trading sessions. In our update,we analyze recent news about the companies featured and detail the movement in the stock. If you would like to feature your publicly traded company in our alerts or on Stockguru.com, email feature@stockguru.com or call (469) 252-3031.
Protein Polymer Technologies, Inc. (OTCBB:PPTI), Tuesday, the shares closed unchanged at $0.20. The volume was 900. The firm which is a biotechnology device company that is a pioneer in protein design and synthesis, recently announced that it has filed a 510(k) application with the U.S. Food and Drug Administration (FDA) for clearance to expand the labeled indications of Surgica's embolization products to include treatment of hypervascular tumors including uterine fibroids, liver and renal tumors. Surgica's proprietary foam embolization products are currently cleared for use in the endovascular management of neurovascular arteriovenous malformations and neoplastic lesions when presurgical devascularization is desirable. Surgica has three FDA-cleared polyvinyl alcohol (PVA) based embolization products -- PVA Plus(TM), MicroStat(TM) and MaxiStat(TM) and one additional product under development, Blocker(TM). "The submission of this application is an important milestone in the regulatory process for advancing the commercialization of Surgica's proprietary embolization products," commented William N. Plamondon III, Chief Executive Officer of PPTI. "This submission further demonstrates our commitment to the use of embolization products to treat a variety of conditions. The expanded indications will allow us to significantly increase our market potential." PPTI completed a worldwide License Agreement with Surgica for its products and technology in December 2005, acquiring the exclusive rights to develop and commercialize Surgica's embolization products.
Protein Polymer Technologies, Inc. is a biotechnology company that discovers and develops innovative therapeutic devices to improve medical and surgical outcomes. The Company focuses on developing technology and products to be used for soft tissue augmentation, tissue adhesives...
|
|
More articles from M2 Presswire
Issues Updates for Sharesholders of Hartcourt Companies, Inc., May 31, 2006
Issues Updates for Shareholders of Delphi Corp., May 31, 2006
The Bellwether Report take time to Dig a Little Deeper into Pilgrim Pe..., May 31, 2006
on Swiss Medica, Inc., May 31, 2006
BellwetherReport.com is Tracking ADC Telecommunications Inc., May 31, 2006
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
|
